Archives
-
RP3-340N1.2 Stabilizes IL-6 mRNA in NSCLC
2026-09-25
The study identifies the lncRNA RP3-340N1.2 as a post-transcriptional regulator that supports IL-6 mRNA stability in non-small cell lung cancer. Knockdown reduced tumor-cell proliferation and migration and weakened tumor-associated macrophage effects, linking an RNA-binding protein interaction to tumor-promoting communication between cells.
-
GPC3-HSP70 mRNA Nanovaccine for HCC
2026-09-24
The study reports an SP94-targeted mRNA nanovaccine encoding repeated GPC3 CTL epitopes fused to HSP70, designed to connect tumor delivery with antigen presentation and T-cell activation. In preclinical experiments, vaccination increased antigen-specific immune responses, and combining it with anti-PD-L1 therapy strengthened antitumor activity; the findings are promising but do not establish clinical efficacy.
-
Murine RNase Inhibitor for RNA Workflows
2026-09-24
Protect RNA during cDNA synthesis, real-time RT-PCR, and in vitro transcription workflows—even when reducing conditions are low. Murine RNase Inhibitor targets pancreatic-type RNases and offers an oxidation-resistant option, but it does not inhibit every RNase or improve circularization by itself.
-
RP3-340N1.2 Stabilizes IL-6 in NSCLC
2026-09-23
The study links the lncRNA RP3-340N1.2 to non-small cell lung cancer progression by showing that its knockdown increases ZC3H12A association with IL-6 mRNA and accelerates IL-6 mRNA decay. Functional experiments further connect this RNA-regulatory mechanism with cancer-cell behavior and macrophage-associated signaling, while leaving important questions for validation in more physiological models.
-
Vidarabine Monohydrate: A Causal Assay Guide
2026-09-23
Vidarabine monohydrate is a nucleoside analog for dissecting viral DNA replication rather than simply ranking antiviral potency. This guide combines chemical handling, temporal assay design, and a carefully bounded lesson from modern molecular pharmacology to improve causal interpretation.
-
β-Pseudouridine: RNA Workflow & Applications
2026-09-22
β-Pseudouridine is a C-glycoside isomer of uridine for investigating RNA structure, translational fidelity, and stress-response biology. This guide separates free-nucleoside assay use from triphosphate-dependent RNA synthesis and translates recent self-amplifying RNA findings into practical experimental choices.
-
p21 mRNA-LNP Delivery for Bladder Cancer
2026-09-22
The reference study develops an intravesical lipid nanoparticle platform for delivering chemically modified p21 mRNA to bladder tumors, addressing the delivery limitations of systemic mRNA therapy. Its preclinical data connect localized p21 restoration with cell-cycle suppression, DNA-damage signaling, apoptosis, tumor growth control, and limited systemic exposure.
-
Trilaurin for Oral Peptide Delivery
2026-09-21
Trilaurin, or Glycerol Tridodecanoate, is a defined C12 triacylglycerol that connects solid lipid microparticle design with enzyme-assisted synthesis. This practical guide covers formulation workflows, digestion-based assays, biocatalytic benchmarking, and troubleshooting for peptide, protein, and lipid research.
-
Diminazene Aceturate: Designing Better Assays
2026-09-21
Diminazene Aceturate is both a trypanocidal research compound and an emerging ACE2 activation probe. This guide presents an assay-design framework for separating antiparasitic activity from mitochondrial and cardiac pathway effects.
-
Cy5-UTP for RNA Imaging: From Probe to Proof
2026-09-20
Cy5-UTP enables direct fluorescent RNA labeling during T7 in vitro transcription. This guide connects Cyanine 5-uridine triphosphate chemistry with spatial assay design, RNA quality controls, FISH, and emerging mRNA-delivery research.
-
Affinity-Purified Goat Anti-Rabbit IgG (H+L)
2026-09-19
Build reproducible Western blot, ELISA, and IHC workflows around an affinity-purified HRP secondary that converts rabbit primary-antibody binding into measurable enzymatic signal. The workflow also shows how PSMD13-focused liver cancer studies can guide tissue controls, paired-sample analysis, and assay optimization.
-
Z-VEID-FMK: Caspase-6 Inhibitor Guide
2026-09-18
Z-VEID-FMK is a cell-permeable, irreversible caspase-6 inhibitor for apoptosis assays and caspase activity measurement. Product specifications and a 2025 rat inflammatory-pain study support its use as a mechanistic research tool, while model transfer and target selectivity require experimental verification.
-
Biodegradable Polyesters for VEGF mRNA Delivery
2026-09-18
The reference study develops three-armed biodegradable polyesters that combine mRNA-complexing cationic behavior with ester-based degradability and intrinsic redox-related activity. In critical limb ischemia, arginine-functionalized particles improved VEGF mRNA delivery while scavenging reactive oxygen species and releasing nitric oxide, providing a multifunctional rationale for therapeutic angiogenesis.
-
8-Chloroadenosine in RNA Stability Research
2026-09-17
8-Chloroadenosine offers a practical way to examine how transcriptional suppression changes RNA stability in cancer models. This article connects its use as a nucleoside analog inhibitor with the RP3-340N1.2–IL-6–ZC3H12A axis while emphasizing rigorous assay interpretation.
-
EZ Cap™ Mouse CD252(OX40L) mRNA Assays
2026-09-17
EZ Cap™ Mouse CD252(OX40L) mRNA (m1Ψ, HA tag) enables controlled investigation of OX40L-mediated immune co-stimulation. This guide presents a layered assay framework that separates mRNA expression, ligand display, receptor engagement, and functional T-cell outcomes.